Adimmune Corporation (4142) Stock Price & Analysis
4142 Stock Chart & Stats
- Day’s Range
- TWD 15.65 - TWD 16.50
- 52-Week Range
- TWD 15.65 - TWD 22.50
- Previous Close
- TWD 16.60
- Volume
- N/A
- Average Volume (3M)
- 1.05M
- Market Cap
- TWD 7.02B
- Enterprise Value
- TWD 8.70B
- Total Cash (Recent Filing)
- TWD 1.82B
- Total Debt (Recent Filing)
- TWD 3.03B
- Price to Earnings (P/E)
- ―
- Beta
- 0.46
- Next Earnings
- Nov 18, 2026 (Est.)
- EPS Estimate
- -0.04
- Last Dividend Ex-Date
- Sep 14, 2021
- Dividend Yield
- N/A
4142 FAQ
What was Adimmune Corporation’s price range in the past 12 months?
What is Adimmune Corporation’s market cap?
When is Adimmune Corporation’s upcoming earnings report date?
How were Adimmune Corporation’s earnings last quarter?
Is Adimmune Corporation overvalued?
Does Adimmune Corporation pay dividends?
What is Adimmune Corporation’s EPS estimate?
How many shares outstanding does Adimmune Corporation have?
What happened to Adimmune Corporation’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Adimmune Corporation?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Adimmune Corporation
Adimmune Corporation, a Taiwanese pharmaceutical company, specializes in the production and distribution of human vaccines. Its comprehensive product portfolio includes a range of critical immunizations. Key offerings feature the quadrivalent influenza vaccine, AdimFlu-S, alongside trivalent influenza vaccines and the Influenza A (H1N1) Virus Monovalent Vaccine. The company also provides tetanus toxoid products, vital for post-injury tetanus prevention, and Japanese encephalitis vaccines. Furthermore, Adimmune supplies purified Tuberculin and extends its expertise through contract manufacturing services. Established in 1965, the company initially operated under the name Kuo Kwang Serum and Vaccine Manufacture Co., Ltd. It subsequently rebranded as Adimmune Corporation in 2001 and maintains its headquarters in Taichung, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Chi-Hsien Chan
- Employees
- 564
- Website
- www.adimmune.com.tw
- Address
- No. 3, Tanxing Road, Taichung, TX, 427003, TW
Adimmune Corporation (4142) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |

